GWM
MAXR

Geneos Wealth Management’s Maxar Technologies Inc. Common Stock MAXR Stock Holding History

Geneos Wealth Management’s Portfolio MAXR Stock Details MAXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-625
Closed -$24K – 2851
2022
Q1 		$24K Hold
625
– – ﹤0.01% 1729
2021
Q4 		$18K Sell
625
-270
-30% -$7.83K ﹤0.01% 1952
2021
Q3 		$25K Buy
895
+270
+43% +$8.67K ﹤0.01% 1815
2021
Q2 		$25K Buy
+625
New +$22.3K ﹤0.01% 1808

Other funds holding MAXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
SAM
Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return

Geneos Wealth Management's MAXR Position: Q2 2022 in Review

Geneos Wealth Management sold out of Maxar Technologies Inc. Common Stock (MAXR) in Q2 2022, closing a stake of 625 shares — an estimated $24K sold.

Geneos Wealth Management first reported a position in MAXR in Q2 2021 and held it in 4 quarters. The position peaked at $25K in Q3 2021. 219 funds tracked by Wall St. Rank hold MAXR as of Q2 2022.

  • Geneos Wealth Management reported no remaining Maxar Technologies Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 625 Maxar Technologies Inc. Common Stock shares in Q2 2022, an estimated $24K.
  • Geneos Wealth Management first reported a position in Maxar Technologies Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Geneos Wealth Management's Maxar Technologies Inc. Common Stock position peaked at $25K in Q3 2021.
  • 219 funds tracked by Wall St. Rank held Maxar Technologies Inc. Common Stock as of Q2 2022.

Based on Geneos Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.